<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32530733</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>02</Day></PubDate></JournalIssue><Title>Human vaccines &amp; immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Assessing the vaccine effectiveness for hand, foot, and mouth disease in Guangzhou, China: a time-series analysis.</ArticleTitle><Pagination><StartPage>217</StartPage><EndPage>223</EndPage><MedlinePgn>217-223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2020.1763076</ELocationID><Abstract><AbstractText><b>Objective</b>: Hand, foot, and mouth disease (HFMD) is an important public health issue in China. Although efficacy has been demonstrated by randomized controlled trials, the evidence for effectiveness of the monovalent Enterovirus 71 (EV71) vaccine against HFMD remains unknown. This study aimed to assess the vaccine effectiveness for HFMD in Guangzhou, China. <b>Methods</b>: Routinely collected vaccination and HFMD surveillance data were captured from the China Information System for Disease Control and Prevention. We estimated the EV71 vaccine effectiveness using spatial ecologic and time-series analysis approaches. <b>Results</b>: A total of 174,002 HFMD cases under 5&#xa0;years of age were reported to the Guangzhou, China surveillance system from January 2016 to December 2018. A total of 408,664 children completed a two-dose EV71 vaccination series. In an ecologic analysis, a two-dose EV71 vaccination rate above the median conferred lower HFMD risk relative to a vaccination rate below the median (ratio ratio&#xa0;=&#xa0;0.955, 95% confidence interval (CI): 0.949, 0.962; <i>P</i> &lt;&#xa0;.001). In the time-series approach, 0.9% fewer HFMD cases were associated with a 1% increase in the two-dose EV71 vaccination rate, but without statistical significance (<i>P</i> =&#xa0;.094). However, we detected statistically significant protective associations for HFMD among children 3&#xa0;years of age (0.9% fewer HFMD cases with a 1% increased vaccination rate; <i>P</i> =&#xa0;.046), and for EV71 (1.4%; <i>P</i> =&#xa0;.012) and "other viruses" (1.3%; <i>P</i> =&#xa0;.002), although not for Coxsackievirus A16 (CVA16). <b>Conclusion</b>: Our findings, based on real-world data, provide evidence of EV71 vaccine effectiveness for preventing EV71 and "other" viruses associated with HFMD. An expanded program of EV71 vaccination is urgently needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Zhicheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-1155-8443</Identifier><AffiliationInfo><Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Immunization Programme Planning, Guangzhou Center for Disease Control and Prevention , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><Identifier Source="ORCID">0000-0002-0028-5494</Identifier><AffiliationInfo><Affiliation>Departments of Environmental Health Sciences and Epidemiology and Biostatistics, School of Public Health, University at Albany, State University of New York , Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhoubin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Communicable Disease Control and Prevention, Guangzhou Center for Disease Control and Prevention , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhicong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Communicable Disease Control and Prevention, Guangzhou Center for Disease Control and Prevention , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jianyun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Communicable Disease Control and Prevention, Guangzhou Center for Disease Control and Prevention , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jianxiong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Immunization Programme Planning, Guangzhou Center for Disease Control and Prevention , Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Yuantao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-8024-5312</Identifier><AffiliationInfo><Affiliation>Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University , Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="Y">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="Y">Viral Vaccines</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hand</Keyword><Keyword MajorTopicYN="N">enterovirus 71 vaccine</Keyword><Keyword MajorTopicYN="N">foot</Keyword><Keyword MajorTopicYN="N">mouth disease</Keyword><Keyword MajorTopicYN="N">vaccine effectiveness</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32530733</ArticleId><ArticleId IdType="pmc">PMC7872061</ArticleId><ArticleId IdType="doi">10.1080/21645515.2020.1763076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Western Pacific . Hand, foot, and mouth disease. WHO; 2019. 
April
23
[accessed 2020March25]. https://www.who.int/westernpacific/emergencies/surveillance/archives/hand-foot-and-mouth-disease.</Citation></Reference><Reference><Citation>Cox B, Hand LF.. Foot, and mouth diseasehand, foot, and mouth diseasehand, foot, and mouth disease. JAMA. 2018;320(23):2492. doi:10.1001/jama.2018.17288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.17288</ArticleId><ArticleId IdType="pubmed">30561482</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Disease Prevention and Control . Epidemic situation of notifiable infectious diseases in China (in Chinese). National Health Commission of the People&#x2019;s Republic China; 2019. 
April
24
[accessed 2020 March25]. http://www.nhc.gov.cn/wjw/rdts/list.shtml.</Citation></Reference><Reference><Citation>Zhang R, Dai T, Jia X, Li Y.. Comprehensive evaluation of health effect of notifiable infectious diseases in China (in Chinese). China Med Her. 2015;12(12):50&#x2013;53.</Citation></Reference><Reference><Citation>Health CFP . Hand, foot and mouth disease. Hong Kong, China: Department of Health; 2019. 
June
27
[accessed 2020 March25]. https://www.chp.gov.hk/en/healthtopics/content/24/23.html.</Citation></Reference><Reference><Citation>Shimizu H, Nakashima K. Surveillance of hand, foot, and mouth disease for a vaccine. Lancet Infect Dis. 2014;14(4):262&#x2013;63. doi:10.1016/S1473-3099(13)70330-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70330-X</ArticleId><ArticleId IdType="pubmed">24485992</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016:1&#x2013;8. doi:10.1586/14760584.2016.1138862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao E, Wu S, Xu Q, Zeng Y, Tan N, He S, Yang Y, Wei J. Enterovirus type 71&#x2011;immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16 in vitro. Exp Ther Med. 2019;18:332&#x2013;41. doi:10.3892/etm.2019.7529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.7529</ArticleId><ArticleId IdType="pmc">PMC6566110</ArticleId><ArticleId IdType="pubmed">31258670</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Li H, Yue L, Song X, Xie T, Ma S, Meng H, Zhang Y, He X, Long R, et al. A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro. Virol J. 2017;14(1):206. doi:10.1186/s12985-017-0872-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0872-8</ArticleId><ArticleId IdType="pmc">PMC5659012</ArticleId><ArticleId IdType="pubmed">29073897</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Liao Q, Ooi MH, Cowling BJ, Chang Z, Wu P, Liu F, Li Y, Luo L, Yu S, et al. Epidemiology of recurrent hand, foot and mouth disease, China, 2008-2015. Emerg Infect Dis. 2018;24(3):432&#x2013;42. doi:10.3201/eid2403.171303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2403.171303</ArticleId><ArticleId IdType="pmc">PMC5823341</ArticleId><ArticleId IdType="pubmed">29460747</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L, Liu Y, Li S, Zhao H, Lin Q, Yu H, Huang X, Zheng Q, Cheng T, Xia N. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice. Vaccine. 2016;34(48):5938&#x2013;45. doi:10.1016/j.vaccine.2016.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.10.018</ArticleId><ArticleId IdType="pubmed">27771182</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang S Cross-protection of Enterovirus 71 vaccine and construction of its gene recombinant mycobacterium smegmatis (in Chinese) [dissertation]. Guilin (China): Guilin Medical University; 2018.</Citation></Reference><Reference><Citation>Zhu F, Meng F, Li J, Li X, Mao Q, Tao H, Zhang Y, Yao X, Chu K, Chen Q, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre,randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013;381(9882):2024&#x2013;32. doi:10.1016/S0140-6736(13)61049-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61049-1</ArticleId><ArticleId IdType="pubmed">23726161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Song J, Wang J, Li Y, Deng H, Li M, Gao N, Zhai S, Dang S, Zhang X, et al. Cost-effectiveness of a national enterovirus 71 vaccination program in China. Plos Neglect Trop D. 2017;11(9):e5899. doi:10.1371/journal.pntd.0005899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005899</ArticleId><ArticleId IdType="pmc">PMC5608421</ArticleId><ArticleId IdType="pubmed">28892475</ArticleId></ArticleIdList></Reference><Reference><Citation>Comprehensive statistical office . Statistical yearbook of Guangdong. Statistics Bureau of Guangdong; 2019. 
September
29
[accessed 2020 March25]: http://stats.gd.gov.cn/gdtjnj/index.html.</Citation></Reference><Reference><Citation>Hohle M, Siedler A, Bader HM, Ludwig M, Heininger U, Von Kries R. Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiol Infect. 2011;139(11):1710&#x2013;19. doi:10.1017/S0950268810002815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268810002815</ArticleId><ArticleId IdType="pubmed">21156098</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyono K. Establishing a direct connection between detrended fluctuation analysis and Fourier analysis. Phys Rev E Stat Nonlin Soft Matter Phys. 2015;92(4):42925. doi:10.1103/PhysRevE.92.042925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1103/PhysRevE.92.042925</ArticleId><ArticleId IdType="pubmed">26565322</ArticleId></ArticleIdList></Reference><Reference><Citation>Experts from China CDC . Core information of prevention and control of hand, foot and mouth disease (in Chinese). China CDC; 2018. 
March
26
[accessed 2020 March25]. http://www.chinacdc.cn/jkzt/crb/bl/szkb/zstd/201803/t20180326_159976.html.</Citation></Reference><Reference><Citation>Li Y, Zhou Y, Cheng Y, Wu P, Zhou C, Cui P, Song C, Liang L, Wang F, Qiu Q, et al. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study. Lancet Child Adolesc Health. 2019;3(10):697&#x2013;704. doi:10.1016/S2352-4642(19)30185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(19)30185-3</ArticleId><ArticleId IdType="pmc">PMC8713082</ArticleId><ArticleId IdType="pubmed">31375313</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, An Z, Huo D, Jia L, Li J, Yang Y, Liang Z, Wang Q, Wang H. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China. Hum Vacc Immunother. 2019;15(5):1183&#x2013;90. doi:10.1080/21645515.2019.1581539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1581539</ArticleId><ArticleId IdType="pmc">PMC6605830</ArticleId><ArticleId IdType="pubmed">30779680</ArticleId></ArticleIdList></Reference><Reference><Citation>InterNations GO. 
The Chinese education system. InterNations GO; 2020. 
January
30
[accessed 2020 March25]. https://www.internations.org/go/moving-to-china/education.</Citation></Reference><Reference><Citation>Du Z, Zhang W, Zhang D, Yu S, Hao Y. Epidemiological characteristics of severe cases of hand, foot, and mouth disease in Guangdong, China. Biostatistics Epidemiol. 2018;2(1):99&#x2013;114. doi:10.1080/24709360.2018.1469809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/24709360.2018.1469809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F, Xu W, Xia J, Liang Z, Liu Y, Zhang X, Tan X, Wang L, Mao Q, Wu J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. New Engl J Med. 2014;370(9):818&#x2013;28. doi:10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>